×

Functional benefits of a chorioretinal anastomosis at 2 years in eyes with a central retinal vein occlusion treated with ranibizumab compared with ranibizumab monotherapy

Functional benefits of a chorioretinal anastomosis at 2 years in eyes with a central retinal vein occlusion treated with ranibizumab compared with ranibizumab monotherapy.

McAllister ILSmithies LAChen FKMackey DA, Sanfilippo PG.

BMJ Open Ophthalmol. 2021 Mar 8;6(1):e000728. doi: 10.1136/bmjophth-2021-000728. eCollection 2021.

PMID: 33768164

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

Request an appointment